Total Payments
$8,886
2024 Payments
$1,289
Companies
35
Transactions
502
Medicare Patients
20,178
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$8,863 (99.8%)
Education$22.09 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,863 | 500 | 99.8% |
| Education | $22.09 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,421 | 122 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,486 | 115 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $636.37 | 31 | $0 (2024) |
| GENZYME CORPORATION | $624.26 | 28 | $0 (2024) |
| Amgen Inc. | $598.89 | 30 | $0 (2024) |
| UCB, Inc. | $519.95 | 30 | $0 (2024) |
| Lilly USA, LLC | $417.53 | 26 | $0 (2024) |
| PFIZER INC. | $403.44 | 28 | $0 (2024) |
| Janssen Biotech, Inc. | $240.05 | 15 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $236.98 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,289 | 63 | ABBVIE INC. ($354.30) |
| 2023 | $1,126 | 69 | AbbVie Inc. ($370.36) |
| 2022 | $1,362 | 75 | ABBVIE INC. ($359.37) |
| 2021 | $1,152 | 77 | AbbVie Inc. ($328.19) |
| 2020 | $900.00 | 60 | AbbVie Inc. ($230.29) |
| 2019 | $1,482 | 69 | AbbVie, Inc. ($409.66) |
| 2018 | $585.44 | 37 | AbbVie, Inc. ($190.69) |
| 2017 | $989.51 | 52 | Novartis Pharmaceuticals Corporation ($189.36) |
All Payment Transactions
502 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.79 | General |
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.61 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.85 | General |
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: Immunology | ||||||
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $0.82 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $118.31 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.85 | General |
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.68 | General |
| Category: Immunology | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.75 | General |
| 09/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: Inflammation | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Dermatology | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Immunology | ||||||
| 08/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Immunology | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: Dermatology | ||||||
| 08/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.29 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Immunology | ||||||
| 07/31/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Immunology | ||||||
| 07/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: DERMATOLOGY | ||||||
| 07/24/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 4,016 | 7,075 | $574,580 | $261,672 |
| 2022 | 33 | 4,805 | 9,052 | $738,439 | $349,529 |
| 2021 | 37 | 5,422 | 12,939 | $1.0M | $395,405 |
| 2020 | 35 | 5,935 | 11,211 | $1.1M | $414,681 |
Total Patients
20,178
Total Services
40,277
Medicare Billing
$1.4M
Procedure Codes
133
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 695 | 961 | $105,710 | $57,196 | 54.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 486 | 574 | $86,100 | $35,063 | 40.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 345 | 398 | $53,730 | $30,165 | 56.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 546 | 708 | $60,180 | $23,454 | 39.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 456 | 562 | $61,820 | $21,244 | 34.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 132 | 150 | $31,500 | $17,683 | 56.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 430 | 2,483 | $24,830 | $11,584 | 46.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 38 | 45 | $14,400 | $7,986 | 55.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 120 | 167 | $14,195 | $6,558 | 46.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 96 | 96 | $13,440 | $6,486 | 48.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 36 | 42 | $10,500 | $5,089 | 48.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 128 | 192 | $10,080 | $4,992 | 49.5% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 20 | 23 | $7,245 | $4,431 | 61.2% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 26 | 27 | $7,830 | $3,940 | 50.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 17 | 17 | $6,800 | $3,549 | 52.2% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 22 | 24 | $8,880 | $3,080 | 34.7% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 31 | 34 | $8,160 | $2,843 | 34.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 60 | 60 | $8,700 | $2,411 | 27.7% |
| 69100 | Biopsy of ear | Office | 2023 | 38 | 43 | $11,180 | $2,357 | 21.1% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $4,620 | $2,273 | 49.2% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 65 | 76 | $5,320 | $2,216 | 41.7% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 17 | 17 | $4,250 | $2,125 | 50.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 15 | $2,400 | $1,410 | 58.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 16 | 19 | $3,135 | $1,015 | 32.4% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 32 | 34 | $3,570 | $948.00 | 26.6% |
About Dr. Robert Siragusa, MD
Dr. Robert Siragusa, MD is a Dermatology healthcare provider based in Panama City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255320545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Siragusa, MD has received a total of $8,886 in payments from pharmaceutical and medical device companies, with $1,289 received in 2024. These payments were reported across 502 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($8,863).
As a Medicare-enrolled provider, Siragusa has provided services to 20,178 Medicare beneficiaries, totaling 40,277 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Panama City, FL
- Active Since 10/19/2005
- Last Updated 05/28/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1255320545
Products in Payments
- SKYRIZI (Biological) $1,108
- COSENTYX (Biological) $852.03
- DUPIXENT (Biological) $824.51
- Humira (Biological) $564.02
- TALTZ (Drug) $394.50
- EUCRISA (Drug) $391.57
- Enbrel (Biological) $387.71
- COSENTYX (Drug) $343.08
- RINVOQ (Biological) $340.64
- Cimzia (Drug) $285.56
- Bimzelx (Biological) $234.39
- LIBTAYO (Biological) $231.16
- Otezla (Drug) $221.72
- Skyrizi (Biological) $198.54
- HUMIRA (Biological) $193.38
- Erivedge (Biological) $168.60
- DUPIXENT DUPILUMAB INJECTION (Biological) $159.40
- LEVULAN KERASTICK (Drug) $126.86
- Sotyktu (Drug) $122.81
- TREMFYA (Drug) $121.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Panama City
Dr. Jon Ward, Md, MD
Dermatology — Payments: $15,137
Dermatology $15,137
Charles Kovaleski, Md, MD
Dermatology — Payments: $10,075
Dermatology $10,075
Alexander Davis, Md, MD
Dermatology — Payments: $4,724
Dermatology $4,724
Dr. Christopher Wolfe, Do, DO
Dermatology — Payments: $2,755
Dermatology $2,755